Transcutaneous Pulsed Radiofrequency in Migraine
Comparison of Transcutaneous Pulsed Radiofrequency Therapy and Greater Occipital Nerve Block Efficiency in Migraine Headache
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of the investigator is to compare the efficacy of greater occipital nerve block and transcutaneous pulsed radiofrequency treatment in migraine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2021
CompletedFirst Submitted
Initial submission to the registry
August 11, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2023
CompletedFebruary 3, 2023
February 1, 2023
2 years
August 11, 2022
February 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Migraine Disability Assessment Test
The MIDAS questionnaire is an important part of a package of educational, investigative, and therapeutic measures, and could play a major role in improving the care of patients with migraine and other types of headache.
Baseline
Secondary Outcomes (1)
Visual analog scale (VAS)
Baseline, Week 4
Study Arms (2)
GON block group
ACTIVE COMPARATOR30 patients who underwent greater occipital nerve block
Transcutaneous pulsed RF group
ACTIVE COMPARATOR30 patients who underwent greater occipital nerve pulsed radiofrequency
Interventions
2.5 cc bupivacain injection will be administered by approaching the greater occipital nerve under ultrasound guidance.
Pulsed radiofrequency current will be applied through transcutaneous pads adhered over the greater occipital nerve trace on the nape.
Eligibility Criteria
You may qualify if:
- Chronic Migraine
You may not qualify if:
- Other headaches will not accompany (tension-type headache, cluster...)
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diskapi Yildirim Beyazıt Teaching and Research Hospital
Ankara, Altındğ, Turkey (Türkiye)
Related Publications (1)
Perdecioglu GRG, Ates MP, Yuruk D, Can E, Yildiz G, Akkaya OT. A new neuromodulation method in chronic migraine; non-invasive pulsed radiofrequency, a single-blinded, randomised, controlled trial. Ir J Med Sci. 2024 Jun;193(3):1487-1493. doi: 10.1007/s11845-023-03598-x. Epub 2023 Dec 26.
PMID: 38147268DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
mehlika panpallı ateş
Diskapi TRH
- STUDY DIRECTOR
ömer taylan akkaya
Diskapi TRH
- STUDY CHAIR
Hüseyin Alp Alptekin
Diskapi TRH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, medical doctor
Study Record Dates
First Submitted
August 11, 2022
First Posted
August 12, 2022
Study Start
June 22, 2021
Primary Completion
June 22, 2023
Study Completion
August 22, 2023
Last Updated
February 3, 2023
Record last verified: 2023-02